Paul Stellato Joins Zimmer Biomet as Vice President,
Controller and Chief Accounting Officer
WARSAW,
Ind., May 16, 2022 /PRNewswire/ -- Zimmer Biomet
Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology
leader, today announced the appointment of Paul Stellato as Vice President, Controller and
Chief Accounting Officer. Prior to joining Zimmer Biomet, Mr.
Stellato served as Vice President, Finance, Global Business
Services at Xylem Inc.
"With more than two decades of experience and a demonstrated
track record of success in all areas of financial services, Paul
will be a great addition to our leadership team in his new role,"
said Suky Upadhyay, Executive Vice
President and Chief Financial Officer of Zimmer Biomet. "His
experience and expertise in key finance areas including
controllership, FP&A, investor relations and internal audit
will be extremely valuable as we continue to drive our business
forward."
Prior to his most recent role at Xylem Inc., Mr. Stellato served
as the company's Vice President, Controller and Chief Accounting
Officer and as Vice President Finance, Financial Planning and
Analysis. Previously, he spent eight years at ITT Corporation,
where he held various roles of increasing responsibility in the
finance organization, including General Auditor and Manager,
Investor Relations. Mr. Stellato spent the early part of his career
in public accounting with both Andersen and Ernst & Young. He
holds a Bachelor of Science degree in Accountancy from Villanova University and an MBA in finance from NYU
Stern School of Business. He is also a Certified Public
Accountant.
About Zimmer Biomet
Zimmer Biomet is a global medical technology leader
with a comprehensive portfolio designed to maximize mobility and
improve health. We seamlessly transform the patient experience
through our innovative products and suite of integrated digital and
robotic technologies that leverage data, data analytics and
artificial intelligence.
With 90+ years of trusted leadership and proven expertise,
Zimmer Biomet is positioned to deliver the highest quality
solutions to patients and providers. Our legacy continues to
come to life today through our progressive culture of evolution and
innovation.
For more information about our product portfolio, our operations
in 25+ countries and sales in 100+ countries or about joining our
team, visit www.zimmerbiomet.com or follow Zimmer Biomet
on Twitter at www.twitter.com/zimmerbiomet.
Cautionary Note Regarding Forward-Looking Statements
This news release contains forward-looking statements within
the meaning of the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. Forward-looking statements include,
but are not limited to, statements concerning Zimmer Biomet's
expectations, plans, prospects, and product and service offerings,
including new product launches and potential clinical successes.
Such statements are based upon the current beliefs and expectations
of management and are subject to significant risks, uncertainties
and changes in circumstances that could cause actual outcomes and
results to differ materially. For a list and description of some of
such risks and uncertainties, see Zimmer Biomet's periodic reports
filed with the U.S. Securities and Exchange Commission (SEC). These
factors should not be construed as exhaustive and should be read in
conjunction with the other cautionary statements that are included
in Zimmer Biomet's filings with the SEC. Forward-looking statements
speak only as of the date they are made, and Zimmer Biomet
disclaims any intention or obligation to update or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise. Readers of this news release are
cautioned not to rely on these forward-looking statements, since
there can be no assurance that these forward-looking statements
will prove to be accurate. This cautionary statement is applicable
to all forward-looking statements contained in this news
release.
ZBH-Fin
Media
|
|
Investors
|
Meredith
Weissman
|
|
Keri Mattox
|
703-346-3127
|
|
215-275-2431
|
meredith.weissman@zimmerbiomet.com
|
|
keri.mattox@zimmerbiomet.com
|
|
|
|
|
|
Ezgi Yagci
617-549-2443
ezgi.yagci@zimmerbiomet.com
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/zimmer-biomet-announces-appointment-of-new-chief-accounting-officer-301547550.html
SOURCE Zimmer Biomet Holdings, Inc.